In chronic inflammatory conditions, the stimulatory effect of PDGF on connective tissue cells may lead to tissue fibrosis, consistent with our data (Fig. 3A and 4) [57], to extend, the use of anti-PDGF-B can be a good therapeutic approach to progressive renal disease [56]. The gene discussed is PDGFB; the disease is kidney disorder.